Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Keryx
Keryx
Keryx Biopharma gets U.S. approval for kidney drug
Yahoo/Reuters
Fri, 09/5/14 - 11:58 am
FDA
Keryx
Zerenex
chronic kidney disease
September Biotech Calendar
TheStreet.com
Tue, 08/26/14 - 10:08 am
Keryx
Orexigen
AstraZeneca
Nektar
Salix
Alimera
Amarin
Merck
EXACT Sciences
NPS Pharmaceuticals
Keryx touts its kidney drug with an FDA decision around the corner
Fierce Biotech
Fri, 07/25/14 - 11:14 am
Keryx
FDA
hyperphosphatemia
kidney dialysis
Zerenex
Keryx Biopharma: Approval Delay Does Not Change Zerenex Prospects Or Differentiation
Seeking Alpha
Fri, 05/30/14 - 12:28 pm
Keryx
Zerenex
Keryx announces FDA extends PDUFA date for Zerenex
The Fly on the Wall
Fri, 05/23/14 - 07:05 am
FDA
Zerenex
Keryx
Zerenex For The Treatment Of Hyperphosphatemia: A New Use For An Old Compound
Seeking Alpha
Tue, 02/25/14 - 10:59 am
hyperphosphatemia
Zerenex
Keryx
4 Biotech Stocks Making Big Moves
Wall St Cheat Sheet
Fri, 01/17/14 - 05:31 pm
Halozyme
Pacific Biosciences
Keryx
Intercept Pharma
Oppenheimer Sees Five Biotech Stocks to Buy With Potential 50% Upside, or More
24/7 Wall St
Tue, 01/7/14 - 11:47 am
Celldex Therapeutics
Immunomedics
Keryx
Merrimack Pharmaceuticals
Protalix BioTherapeutics
22 Biotech Stock Predictions for 2014
TheStreet.com
Mon, 01/6/14 - 09:47 am
biotech
Vertex Pharmaceuticals
Orexigen
Retrophin
Valeant Pharmaceuticals
Questcor
Biomarin
Merck
NeoStem
Amgen
Gilead Sciences
Vanda
Keryx
Peregrine Pharmaceuticals
CelSci
Regeneron
Cempra
Dendreon
Clovis Oncology
Halozyme
NPS Pharmaceuticals
Understanding Zerenex's Patent Protection And Latest Issuance
Seeking Alpha
Tue, 12/31/13 - 10:13 am
Zerenex
patents
Keryx
The Future Is Bright: Keryx Biopharmaceuticals Receives Patent Protection
Wall St Cheat Sheet
Thu, 12/19/13 - 11:34 am
Keryx
patents
Zerenex
3 Bold Predictions for Keryx Biopharmaceuticals in 2014
Motley Fool
Mon, 12/16/13 - 08:13 am
Keryx
chronic kidney disease
Zerenex
3 Drugmakers to Watch in the New Year
Motley Fool
Wed, 12/11/13 - 11:10 am
pimavanserin
Acadia
Zerenex
Keryx
Iclusig
Ariad Pharmaceuticals
Keep a Close Watch on Geron, Keryx, and Sangamo Today
Motley Fool
Fri, 12/6/13 - 10:21 am
Geron
Keryx
Sangamo BioSciences
2014 FDA Drug Approval Decision Calendar
TheStreet.com
Wed, 11/27/13 - 08:39 am
FDA
drug approvals
GSK
Gilead
Theravance
Auxilium
Amarin
Bristol-Myers Squibb
Biogen Idec
Pozen
Vanda
Chelsea Therapeutics
pSivida
Alimera
United Therapeutics
Biomarin
JNJ
Pharmacyclics
Celgene
MannKind
Santarus
AstraZeneca
Durata Therapeutics
Eli Lilly
Omeros
BioDelivery Sciences
Anacor
Keryx
Cubist Pharmaceuticals
Nektar
Zerenex- The New Spark For Keryx?
Seeking Alpha
Mon, 11/25/13 - 10:57 am
Zerenex
Keryx
Sanofi
OPKO Health
Why Doctors, Dialysis Providers And Investors Are Excited About Zerenex
Seeking Alpha
Mon, 11/11/13 - 11:39 am
dialysis
Zerenex
Keryx
This Week in Biotech
Motley Fool
Sun, 11/10/13 - 12:56 pm
Keryx
Geron
Arena
Eisai
Vivus
Curis
Immunogen
Keryx's kidney drug meets main goals of mid-stage study
Yahoo/Reuters
Tue, 11/5/13 - 09:56 am
Keryx
Zerenex
chronic kidney disease
3 Things You Need to Know from Keryx's Stifel Conference Presentation
Motley Fool
Sat, 09/14/13 - 11:02 am
Keryx
chronic kidney disease
dialysis
hyperphosphatemia
Zerenex
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
next ›
last »